End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
33.41
CNY
|
-1.04%
|
|
+1.43%
|
-19.42%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
42,660
|
46,475
|
70,342
|
82,087
|
72,565
|
58,472
|
-
|
-
|
Enterprise Value (EV)
1 |
41,966
|
44,913
|
67,931
|
80,237
|
69,604
|
54,592
|
52,715
|
51,885
|
P/E ratio
|
15.1
x
|
16.5
x
|
30.6
x
|
32.8
x
|
25.6
x
|
17.8
x
|
14.6
x
|
13.1
x
|
Yield
|
1.15%
|
0.87%
|
0.72%
|
0.62%
|
1.4%
|
1.57%
|
1.78%
|
1.96%
|
Capitalization / Revenue
|
1.2
x
|
1.38
x
|
2.04
x
|
2.18
x
|
1.79
x
|
1.3
x
|
1.18
x
|
1.11
x
|
EV / Revenue
|
1.18
x
|
1.33
x
|
1.97
x
|
2.13
x
|
1.71
x
|
1.21
x
|
1.07
x
|
0.99
x
|
EV / EBITDA
|
11
x
|
11.5
x
|
20.1
x
|
21.7
x
|
16.6
x
|
11.2
x
|
9.28
x
|
8.06
x
|
EV / FCF
|
-
|
-
|
-
|
66.6
x
|
29.8
x
|
24.2
x
|
18
x
|
15.1
x
|
FCF Yield
|
-
|
-
|
-
|
1.5%
|
3.35%
|
4.14%
|
5.55%
|
6.6%
|
Price to Book
|
3.47
x
|
3.18
x
|
4.24
x
|
4.42
x
|
3.46
x
|
2.49
x
|
2.16
x
|
1.93
x
|
Nbr of stocks (in thousands)
|
1,749,810
|
1,749,810
|
1,749,810
|
1,753,995
|
1,750,240
|
1,750,142
|
-
|
-
|
Reference price
2 |
24.38
|
26.56
|
40.20
|
46.80
|
41.46
|
33.41
|
33.41
|
33.41
|
Announcement Date
|
4/27/20
|
4/20/21
|
4/27/22
|
4/13/23
|
4/17/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
35,446
|
33,683
|
34,563
|
37,715
|
40,624
|
45,112
|
49,411
|
52,571
|
EBITDA
1 |
3,811
|
3,916
|
3,371
|
3,691
|
4,190
|
4,888
|
5,679
|
6,440
|
EBIT
1 |
3,397
|
3,477
|
2,856
|
3,061
|
3,453
|
4,106
|
4,892
|
5,498
|
Operating Margin
|
9.58%
|
10.32%
|
8.26%
|
8.12%
|
8.5%
|
9.1%
|
9.9%
|
10.46%
|
Earnings before Tax (EBT)
1 |
3,470
|
3,453
|
2,828
|
3,031
|
3,466
|
4,011
|
4,842
|
5,450
|
Net income
1 |
2,813
|
2,820
|
2,302
|
2,499
|
2,839
|
3,298
|
4,015
|
4,481
|
Net margin
|
7.94%
|
8.37%
|
6.66%
|
6.63%
|
6.99%
|
7.31%
|
8.13%
|
8.52%
|
EPS
2 |
1.610
|
1.612
|
1.315
|
1.428
|
1.621
|
1.881
|
2.290
|
2.556
|
Free Cash Flow
1 |
-
|
-
|
-
|
1,204
|
2,333
|
2,259
|
2,924
|
3,427
|
FCF margin
|
-
|
-
|
-
|
3.19%
|
5.74%
|
5.01%
|
5.92%
|
6.52%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
32.62%
|
55.69%
|
46.22%
|
51.49%
|
53.22%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
48.18%
|
82.2%
|
68.49%
|
72.83%
|
76.48%
|
Dividend per Share
2 |
0.2800
|
0.2300
|
0.2900
|
0.2900
|
0.5800
|
0.5261
|
0.5934
|
0.6553
|
Announcement Date
|
4/27/20
|
4/20/21
|
4/27/22
|
4/13/23
|
4/17/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
8,636
|
8,933
|
9,265
|
9,661
|
9,856
|
10,115
|
10,271
|
10,009
|
10,229
|
10,411
|
11,315
|
11,379
|
11,548
|
11,433
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
586.7
|
887.7
|
758.4
|
740.4
|
674.9
|
953.9
|
844.5
|
910.1
|
744.4
|
1,072
|
1,013
|
1,042
|
878.4
|
1,208
|
-
|
Operating Margin
|
6.79%
|
9.94%
|
8.19%
|
7.66%
|
6.85%
|
9.43%
|
8.22%
|
9.09%
|
7.28%
|
10.3%
|
8.95%
|
9.16%
|
7.61%
|
10.56%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
666.6
|
-
|
835.9
|
903
|
777.9
|
1,068
|
937.1
|
973.6
|
776.3
|
-
|
-
|
Net income
1 |
-
|
-
|
-
|
-
|
517.7
|
-
|
678.5
|
755.2
|
649.8
|
862.4
|
782.6
|
812.5
|
728.6
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
5.25%
|
-
|
6.61%
|
7.55%
|
6.35%
|
8.28%
|
6.92%
|
7.14%
|
6.31%
|
-
|
-
|
EPS
2 |
0.2400
|
0.4025
|
0.3700
|
0.3600
|
0.3000
|
0.4315
|
0.3900
|
0.4300
|
0.3700
|
0.4928
|
0.4487
|
0.4810
|
0.4218
|
0.5500
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.6370
|
-
|
-
|
Announcement Date
|
4/27/22
|
4/27/22
|
8/9/22
|
10/25/22
|
4/13/23
|
4/20/23
|
8/15/23
|
10/24/23
|
4/17/24
|
4/25/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
694
|
1,562
|
2,411
|
1,849
|
2,961
|
3,881
|
5,757
|
6,587
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
1,204
|
2,333
|
2,259
|
2,924
|
3,427
|
ROE (net income / shareholders' equity)
|
25.3%
|
21%
|
14.8%
|
14.2%
|
14%
|
14.5%
|
15%
|
15%
|
ROA (Net income/ Total Assets)
|
13.8%
|
12.4%
|
8.99%
|
-
|
-
|
9.3%
|
9.86%
|
10.8%
|
Assets
1 |
20,341
|
22,833
|
25,599
|
-
|
-
|
35,465
|
40,718
|
41,490
|
Book Value Per Share
2 |
7.030
|
8.360
|
9.480
|
10.60
|
12.00
|
13.40
|
15.40
|
17.30
|
Cash Flow per Share
2 |
1.140
|
1.950
|
1.810
|
1.360
|
2.240
|
2.320
|
2.490
|
2.930
|
Capex
1 |
1,296
|
1,099
|
740
|
1,178
|
1,596
|
1,336
|
1,607
|
1,892
|
Capex / Sales
|
3.65%
|
3.26%
|
2.14%
|
3.12%
|
3.93%
|
2.96%
|
3.25%
|
3.6%
|
Announcement Date
|
4/27/20
|
4/20/21
|
4/27/22
|
4/13/23
|
4/17/24
|
-
|
-
|
-
|
Last Close Price
33.41
CNY Average target price
45.42
CNY Spread / Average Target +35.95% Consensus |
1st Jan change
|
Capi.
|
---|
| -19.42% | 8.09B | | +20.94% | 72.78B | | -1.26% | 24.24B | | +8.80% | 8.59B | | +8.25% | 8.38B | | +5.56% | 4.81B | | +16.83% | 4.32B | | -1.83% | 4.05B | | +26.97% | 3.79B | | +7.68% | 3.34B |
Pharmaceuticals Wholesale
|